Most people with bladder cancer experience visible blood in the urine. The bleeding is typically not associated with other complains such as pain. The bleeding typically goes away for a period of time and then returns. The lack of pain or other symptoms associated with the bleeding causes many to disregard the episode which leads to a delay in seeking medical care. If blood clots begin to form, they may make it difficult to urinate. Other times the bleeding may be microscopic only, detected only on a urine test performed by a lab. Microscopic blood not related to a documented infection, trauma or other obvious cause should always undergo an evaluation to determine the cause. Others symptoms that may be related to bladder include an unusual urge to urinate, increased frequency of voiding or pain with urinating.
Much more rare at presentation are symptoms of advanced bladder cancer. These include trouble urinating from tumor blocking the outflow of the bladder, pain in the flanks from blocked kidneys, or bone pain related to disease that has spread to a bone.
If you have one or more of these symptoms, it does not mean that you have bladder cancer. However, it is important to see a doctor so that if you do have an illness it can be diagnosed and treated as early as possible.
If you or your loved one has been diagnosed with bladder cancer, the team at Memorial Sloan-Kettering Cancer Center and other health care physicians are ready to help. MSKCC offers patients precise diagnostics, innovative treatments, and comprehensive support services – as well as access to new techniques and drugs, and clinical trials of the most-advanced treatment approaches. To learn more please visit http://www.mskcc.org/cancer-care/adult/bladder.
In Memoriam: Maria Floyd & Marvin Traub
USE OF PROCEEDS
The proceeds raised from the Pin Down Bladder Cancer initiatives will go to support Memorial Sloan-Kettering Cancer Center’s (MSKCC) bladder cancer Translational Science Program. The translational science studies focus on the development of early detection strategies to improve more timely diagnosis and a molecular characterization effort designed to identify the critical pathways driving the growth of bladder cancer cells.
The laboratories working on bladder cancer oncogenome studies (cutting edge, detailed molecular analysis of bladder cancer) are specifically looking for new targets for treatment. MSKCC early work has already identified novel pathways driving bladder cancer cell growth. MSKCC is now pursuing the development of appropriate models to study these pathways and how targeted drugs can inhibit cancer growth. The funds from this campaign will go directly into the hands of world class scientists that rapidly provide the advances needed for this disease.
Belt down bladder cancer
Help belt down bladder cancer by wearing your PDBC belt for the month of July. Purchase your belt here and ask your friends and family to sponsor you to wear the belt in the month of July. Take photos of yourself and your loved ones wearing the belt and send them to PDBC to add to our Gallery Page.